Clinical trial
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute…
NCT00002532 · Hannover Medical School, Other · Unknown status
Key facts
| NCT number | NCT00002532 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia |
| Official title | TREATMENT OF ADULT PATIENTS WITH RELAPSING ACUTE LYMPHOCYTIC LEUKEMIA, A MULTICENTER TRIAL |
| Lead sponsor | Hannover Medical School, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, asparaginase, cytarabine, daunorubicin hydrochloride, dexamethasone, etoposide, idarubicin, ifosfamide, leucovorin calcium, methotrexate and 2 more |
| Start date | Jan 1, 1993 |
| First posted | Feb 16, 2004 |
| Last update posted | Aug 7, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: